


Monopar Therapeutics
Biotechnology Research • Wilmette, Illinois, United States • 11-20 Employees
Company overview
| Headquarters | 1000 Skokie Blvd, Wilmette, Illinois 60091, US |
| Phone number | +18473880349 |
| Websites | |
| NAICS | 541714 |
| SIC | 873 |
| Founded | 2015 |
| Employees | 11-20 |
| Socials |
Key Contacts at Monopar Therapeutics
Chandler Robinson
Chief Executive Officer
Max Macaluso
Executive Director, Business And Scientific Operations
Monopar Therapeutics Email Formats
Monopar Therapeutics uses 1 email format. The most common is {last name} (e.g., doe@monopartx.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{last name} | doe@monopartx.com | 100% |
About Monopar Therapeutics
Monopar Therapeutics is a clinical-stage biopharmaceutical company developing ALXN1840, a late-stage therapy for Wilson disease, and a radiopharmaceutical pipeline targeting advanced cancers, including MNPR-101-Zr and MNPR-101-Lu in Phase 1 clinical trials and MNPR-101-Ac225 in late preclinical development.
Monopar Therapeutics revenue & valuation
| Annual revenue | $1,625,545 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,300,000 |
| Total funding | $196,300,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Monopar Therapeutics has 12 employees across 6 departments.
Departments
Number of employees
Funding Data
Explore Monopar Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Monopar Therapeutics Tech Stack
Discover the technologies and tools that power Monopar Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Web servers
JavaScript libraries
Tag managers
Photo galleries
Miscellaneous
UI frameworks
JavaScript libraries
Analytics
Miscellaneous
Font scripts
Frequently asked questions
4.8
40,000 users



